← Back to headlines
Syndax Pharmaceuticals Highlights Sales Surge and 2026 Milestones
Syndax Pharmaceuticals has reported a significant increase in sales for Revuforj and Niktimvo, while also outlining key milestones anticipated for 2026 at a Guggenheim conference.
15 Feb, 13:05 — 15 Feb, 13:05
Sources
Showing 1 of 1 sources
